Posted on February 22, 2015 by Pharmaciststeve
Then they came for the empathetic prescribers, and I did not speak out—
Because I was not an empathetic prescriber.
Then they came for the Pharmacists, and I did not speak out—
Because I was not a Pharmacist.
Then they came for me—and there was no one left to speak for me
Posted on April 30, 2017 by Pharmaciststeve
In the garage at Kenmore Mercy Hospital, volunteers are sifting through and cataloging thousands of prescription pills. They’re pills collected as part the Drug Enforcement Administration’s Prescription Drug Take Back Day .
National Drug Take Back Day
DEA began hosting National Prescription Drug Take-Back events in 2010. At the previous 12 Take-Back Day events, millions pounds of unwanted, unneeded or expired medications were surrendered for safe and proper disposal. At the Take-Back Day in May 2016 over 5,400 sites spread across the nation collected unwanted medications.
So if the DEA has had 12 take back events over the last 7-8 yrs and it is to help curb opiate addiction… Someone must have forgotten to tell all those people who are ODing… in dramatically increasing numbers !
Maybe part of the problem is that typically about 90% of the meds turned in for disposal are NOT CONTROLLED SUBSTANCES...
Since 2012, the number of opiate prescriptions written/filled has been decreasing EVERY YEAR… and the DEA has even reduced the production quotas for pharmaceutical manufacturers (brand and generic) has been recently reduced up to 35% .
Does the typical media outlet just mindlessly print whatever the DEA pushes out as press releases about the numbers involved in abuse/addiction to opiates ? Here is the website https://www.dea.gov/pr/news.shtml where the DEA has archived all the press releases that the HQ and 25 regional offices have sent out since 2002.
Like we have seen with the CDC, when is the media going to WAKE UP and realize that the statically data coming from the various Federal/State bureaucracies …. may or may not have anything to do with reality. Are all of these FACTOIDS being disseminated intentionally to serve a certain agenda of the particular bureaucratic entity ?
Posted on April 29, 2017 by Pharmaciststeve
ROCKLAND (CBS)- Amy Frostland works hard as a waitress to help support her two young boys. And even though her husband gets health insurance through his job, it still takes a big bite out of their budget.
“Health Insurance is ridiculous,” she said.
That is why Amy was stunned when she realized that expensive insurance was not helping her when it comes to paying for her medication.
“If I run my insurance, it’s going to cost me $90 for a three month supply; if I do it without insurance, it is $10 for a three month supply,” she explained.
“It’s a huge problem,” said Todd Brown of the Massachusetts Association of Independent Pharmacists.
Brown says much of the blame lies with pharmacy benefit managers, or PMBs. They act as middlemen between insurance companies and pharmacists to process your prescriptions.
They negotiate prices with drug manufacturers and they handle all the patient claims.
Brown said these little known companies are making billions of dollars in profits.
“When you look at the profit these companies make, it’s excessive. It’s inconsistent with the rest of the health care industry,” he explained.
So how are they making that money? Two class actions suits, one of which was filed in Connecticut, claim it is coming from your co-payment.
“It’s really more of a “you-pay” than co-pay,” said Bob Izard, a Connecticut attorney working on both lawsuits.
Here’s an example from one of the lawsuits in which a Massachusetts woman is the lead plaintiff:
An insurance plan requires a $20 co-payment on all prescription drugs. But the price owed to the pharmacy for the medicine is on $1.75. The suit alleges the PMB pockets the change of $18.25, which is called a ‘clawback’.
“We describe it as basically a massive fraud,” Izzard said.
According to the lawsuits, this is not about high-priced designer drugs.
It involves common, relatively inexpensive drugs millions of people take every day like the antibiotic Azithromycin, the blood pressure medication Lisinopril and cholesterol drugs like the generic form of Lipitor, Atorvastatin.
Patients are largely in the dark about this and the suit alleges the PBMs go to great lengths to make sure it stays that way.
“Pharmacies are prohibited from talking to patients about how much a patient would pay if they just pay cash and didn’t go through their insurance,” Brown explained.
The I-Team reached out to an industry group, a spokesperson for the Pharmaceutical Care Management Association. They said,“Patients should not have to pay more than a network drugstore’s submitted charges to the health plan.”
But when we asked them to clarify, the spokesperson never responded.
Amy says she overpaid by hundreds of dollars for years. “I thought it was robbery, absolute robbery,” she said.
So how do you avoid overpaying? You can call your pharmacy and ask what the cash price for the drug is.
You can either pay that cash price or call your insurance company and ask why are paying more than the drug costs.
The PBM industry came on the scene in late 1969… the new UAW contract with Ford, Chevrolet, Chrysler, International Harvester and John Deere “created” this MIDDLEMAN that inserted itself in the retail/community prescription medication system.
Prior to this time, all pts paid CASH for their prescriptions or “store charge” and 2/3 of the community pharmacies (abt 45,000) were neighborhood “independent pharmacies”. The pt submitted their receipts to their insurance company for reimbursement.
The average prescription price was $4-$5 and there were virtually NO GENERICS and prescriptions were abt 6% of overall healthcare costs. Wholesale prices from the brand name Pharma’s were virtually “static”. Back then, Pharmacists had to manually calculate the retail price from the wholesale prices… wholesale prices were so stable many Pharmacists had memorized the wholesale cost, especially on the “fast movers”… Pharmacy wholesalers worked on a 18%-20% gross profit and community pharmacies worked on a 40%-50% gross profit. Everyone made money, and pts got taken care of … even if they didn’t have the money to pay on a particular day.
Won’t bore you with the details from then to now… but today… PBM industries is dominated by five major players https://www.verywell.com/top-5-pharmacy-benefits-managers-2663840 that control/manage 50%+ of all prescriptions paid for by a PBM. Today, 85%-90% of all prescriptions are paid for thru a PBM and today 85%-90% of all prescriptions are GENERICS… and the average prescription prices is pushing $60.00.
Retail/Community pharmacies are working on < 20% GROSS PROFIT and wholesalers are working on abt 6% GROSS PROFIT and prescriptions are now abt 12% of all medical care costs.
If one applies the CPI (Consumer Price Index) and/or COLA ( Cost of living adjustment) to that average Rx price back in 1970.. today one would expect the average Rx price to be in the $30 range. That would presume that all prescriptions are brand name and all pts paid cash and submit their own claims to their insurance company for reimbursement.
Everything since 1970 was done to save pt and the system money… generics are suppose to be less expensive and the PBM’s would expedite claim processing..
So why is the average prescription price is 50% to 100% higher than would otherwise be expected ? Back in 1970, nearly all insurance companies were “mutual companies”… they were owned by their policy holders and were not for profit entities… During the 90’s most insurance companies – demutalized – becoming publicly held – FOR PROFIT – entities. It is claimed today that these for profit insurance companies … 20%-30% of every premium dollar paid to them is CONSUMED by their corporate infrastructure and profit goals… to help keep the stock market and stockholders happy.
The PBM’s are also FOR-PROFIT companies… they have moved on past their original purpose…It has been reported that PBM’s tell the Pharma’s that if they want their medication on the PBM’s “approved formulary” the Pharma needs to pay a rebate/kickback to the PBM’s… some have reported that could be up to 70% of the wholesale price of the product. The “BIG BOYS” are even suing each other over the “sharing” all of these kickbacks/rebates http://www.npr.org/sections/health-shots/2016/03/21/471301872/anthem-sues-express-scripts-for-a-bigger-slice-of-drug-savings
Some point out how much less that the Veterans Administration pays for medications but the VA has no middlemen like insurance companies and PBM’s and their infrastructure overhead and focus on making a profit. Some believe that the various middlemen in the pharmaceutical medication distribution system consume some 40% -50% of every dollar paid to them to support their infrastructure cost and desire to make a profit.
The reason that our healthcare system is so costly… seems quite clear ?
Posted on April 29, 2017 by Pharmaciststeve
It is generally thought that opiate withdrawal is unpleasant but not life-threatening, but death can, and does, occur. The complications of withdrawal are often underestimated and monitored inadequately. It is essential that clinical management programmes are put in place routinely in jails, prisons and other facilities where withdrawal is likely in order to avert these avoidable deaths.
Death is an uncommon, but catastrophic, outcome of opioid withdrawal. The complications of the clinical management of withdrawal are often underestimated and monitored inadequately. In this commentary we highlight the under-reported risk of death, discuss deaths that occurred during opioid withdrawal in United States and British custodial settings and explore implications for clinical management.
The opioid withdrawal syndrome is well-delineated . Signs and symptoms include dysphoria, insomnia, pupillary dilation, piloerection, yawning, muscle aches, lacrimation, rhinorrhea, nausea, fever, sweating, vomiting and diarrhoea. For short-acting opioids, such as heroin, symptom severity peaks typically at around 2–3 days. The syndrome is generally characterized as a flu-like illness, subjectively severe but objectively mild, that stands in stark contrast to the life-threatening benzodiazepine and alcohol withdrawal syndromes. Indeed, it is often said and, was stated publicly by one prominent medical practitioner, that ‘…no one dies of opiate withdrawal’ .
How could someone die during opiate withdrawal? The answer lies in the final two clinical signs presented above, vomiting and diarrhoea. Persistent vomiting and diarrhoea may result, if untreated, in dehydration, hypernatraemia (elevated blood sodium level) and resultant heart failure. There are documented cases of such deaths occurring during the withdrawal process, all in jail settings, that date back to the late 1990s. In 1998, Judith McGlinchey was incarcerated in the United Kingdom and went into heroin withdrawal . She exhibited persistent vomiting, sudden weight loss and dehydration. The cause of death was attributed to hypoxic brain damage caused by a cardiac arrest. A case of failure of duty of care was argued successfully before the European Court of Human Rights. Recent years have seen a number of similar cases reported in the public press between 2013 and 2016 that occurred in United States jails. We are aware of 10 such reported cases, six females and four males, ranging in age from 18 to 49 years [Supporting information, Appendix S1].
All such deaths are preventable, given appropriate medical management. In each case the process of death appeared prolonged, with ample time to treat the person successfully. Why, then, did they occur? These were cases of neglect, or a lack of medical resources to support the individual. Intravenous re-hydration, for instance, is not regarded as appropriate in non-health-care settings. There is a failure to identify the seriousness of the level of dehydration, and to assume that a quiet prisoner is a good prisoner. Jails process more drug withdrawals than any other single institution, but often do not have medical resources to manage severe withdrawal. Indeed, one study of US jails found that only a quarter had alcohol or drug detoxification services .
There is an urgent need to raise awareness of the risk of a fatal outcome in the presence of poor clinical governance. People can, and do, die from opiate withdrawal. The recent substantial increases in heroin use in the United States  make the management of heroin withdrawal a major clinical issue for the correctional system, as opiate users comprise more than a substantial proportion prison populations . Moreover, as jails are the entry point to the correctional system, they are the most likely to have to deal with acute withdrawal among opioid-dependent inmates.
Can anything be done? Withdrawal protocols for jails exist in the United States . Despite this, the medical management of withdrawal is often described as suboptimal by heroin-dependent inmates . In the cases of the reported deaths in jails this was clearly so. Opiate withdrawal needs to be recognized within the correctional system, and elsewhere, as potentially life-threatening and managed accordingly. This is of particular importance for jails, which are short-stay, local facilities where a heroin user may be incarcerated within an hour of being arrested on the street.
An alternative to withdrawal is to provide opiate substitution therapy to opiate-dependent inmates entering the correctional system. The provision of treatment in such settings has been implemented successfully in many jurisdictions, and is associated with lower mortality rates and better clinical outcomes post-release than those who are opioid-dependent at entry and have an enforced withdrawal [9, 10]. One recent study reported that continued maintenance treatment was associated with a 93% reduction of risk of death in custody during a 10-year period . Similar action providing effective drug treatment is required across custodial settings. This is particularly so for the United States, given the recent epidemic of heroin and opioid dependence, as the number of heroin users entering jails and prison will, in all probability, increase substantially in coming years.
Heroin withdrawal is not a trivial matter. The rising number of deaths from withdrawal in United States jails has received scant attention to date. Given appropriate clinical management, such deaths need not occur.
Posted on April 29, 2017 by Pharmaciststeve
The Williamson City Council voted in favor of joining the drug distribution suit at a special meeting held March 17, 2017. At that meeting, Williamson Councilman York Smith made a motion to obtain the law office of T. Chafin (Truman and Letitia Chafin) to represent the city of Williamson in a lawsuit against major wholesale pharmaceutical companies. The motion was seconded and passed with a vote of 3-0. Councilman Matthew Newsome was not present at the special meeting.
At Thursday’s regular meeting of the Williamson City Council, local pharmacist Nicole McNamee approached the council during public comment to request that the city reconsider the decision to join the lawsuit against drug companies.
“I am the owner of Hurley Drug in Williamson and I am here today to talk to you about the drug distribution lawsuit that the city has joined. I wanted to point out a few things that I think everybody needs to know. It will be detrimental to local businesses and health care providers in our city. I know that you all were told that it would not involve local businesses,” McNamee stated.
McNamee used current proceedings underway in McDowell County, W.Va. McDowell County was one of the first in many counties and municipalities that have joined litigation against drug distribution companies. “It is clear that the lawsuit would have to include all the people supply chain which would start with the manufacturers, the drug wholesalers who deliver to pharmacies and prescribers write the prescriptions and you have patients that get the prescriptions. It would have to involve all of those people to be able to show the full scope of the issue.”
McNamee concluded stating, “I am here to ask you all to reconsider joining the lawsuit because I think it will bring businesses and health care providers into this. We are the people that are in the City of Williamson right now. We pay Business and Occupation taxes (B and O) and we are active members of the community. The problems that we have had in the past are gone and the people that are left here are going to be the ones drug into this either right or wrong. I am asking you to reconsider your position on joining that lawsuit.”
Local physician Dr. Donovan (Dino) Beckett also spoke to the Williamson City Council. Beckett’s comments to council were made after the regular meeting had adjourned. At that time, a council member noticed Beckett in the audience, apologized for failing to call on him and asked if he would like to speak. Beckett also requested that the council reconsider their decision to join the drug distribution lawsuit.
“Business owners will have to hire attorneys and incur a lot of legal costs for things that will be detrimental for the image of the city and the potential of out of pocket cost for legal fees. When you are trying to make ends meet and then you have to deal with something of that nature, that is not going to anything for B and O takes for businesses that are in existence now that we are going to be able to create over a five year period. We would like the council to take that into consideration when looking at that possibility,” Beckett stated.
Williamson Mayor Robert Carlton responded stating, “We are looking at that. We have received information and council will eventually address that in an executive session. I do want to say how much we respect what both of you (Beckett and McNamee) do for the city. Keep up the good work; especially all the nonprofit stuff you are doing,” Carlton said.
Beckett thanked Carlton and stated, “Well, we need some for profit things too.”
The Williamson City Council meets on the second and fourth Thursday each month at 6 p.m. in Council Chambers at Williamson City Hall.
Courtney Harrison is a news reporter for the Williamson Daily News. She can be contacted at [email protected] or at 304-235-4242 ext. 2279.
Posted on April 28, 2017 by Pharmaciststeve
People with chronic fatigue syndrome may have imbalances in their gut bacteria, a new study suggests.
The study found that people with chronic fatigue syndrome had higher levels of certain gut bacteria and lower levels of others compared to healthy people who didn’t have the condition.
The researchers then checked to see if these imbalances also characterized the subset of patients in the study who had irritable bowel syndrome (IBS), an intestinal disorder that is common in people with chronic fatigue syndrome. Results showed that patients did indeed have different patterns of gut bacteria disturbances depending on whether they had only chronic fatigue syndrome or both chronic fatigue syndrome and IBS.
The findings suggest that researchers may be able to divide chronic fatigue syndrome patients into different groups depending on their gut bacteria imbalances, which could aid in the diagnosis and treatment of the disease, the researchers said.
Chronic fatigue syndrome is a disorder in which people have extreme fatigue that is not improved by rest and is not the result of another medical condition. An estimated 35 percent to 90 percent of patients with chronic fatigue syndrome also report abdominal discomfort consistent with symptoms of IBS, the researchers said.
The reason for the link between chronic fatigue syndrome and IBS is not clear; chronic fatigue syndrome may predispose patents to developing IBS, or the two conditions might share underlying causes, the researchers said.
Previous studies have already found district differences in gut bacteria in chronic fatigue syndrome patients compared to healthy people. But the new study is one of the first to look for differences between gut bacteria in chronic fatigue syndrome patients who have IBS and bacteria in those who do not have IBS.
The researchers analyzed fecal samples from 50 patients with chronic fatigue syndrome and 50 healthy people who did not have the condition. Nearly half of the chronic fatigue syndrome patients, 21 out of 50, also had IBS.
The researchers found that differences in the levels of six types of gut bacteria — Faecalibacterium, Roseburia, Dorea, Coprococcus, Clostridium, Ruminococcus and Coprobacillu — were strongly linked with chronic fatigue syndrome. In fact, the relative abundance of these species in participants’ guts could be used to predict whether the patients had chronic fatigue syndrome, the researchers said.
In addition, researchers found that people with chronic fatigue syndrome and IBS had higher levels of a type of bacteria called Alistipes and lower levels of a type of bacteria called Faecalibacterium. Meanwhile the patients who had chronic fatigue syndrome but not IBShad higher levels of a genus of bacteria called Bacteroides but lower amounts of a specific species in this genus called Bacteroides vulgatus.
Some researchers have hypothesized that altered gut bacteria may play a role in the causing chronic fatigue syndrome, because some research shows that a person’s gut bacteria may affect their central nervous system and immune system. However, it’s also possible that changes in gut bacteria are a consequence of having chronic fatigue syndrome.
Future studies should look further into gastrointestinal symptoms and their relation to gut bacteria disturbances in people with chronic fatigue syndrome, the researchers said.
It’s possible that one day researchers could use information about a patient’s gut bacteria, the metabolic pathways that those bacteria are involved in and the immune molecules present in the blood to more accurately diagnosis people with chronic fatigue syndrome and develop more specific treatments for the condition, the researchers said.
The study was published online April 26 in the journal Microbiome.
Posted on April 28, 2017 by Pharmaciststeve
As heroin use continues to take an increasing toll on American lives, public health leaders are looking for novel ideas to address the epidemic. “Safe consumption sites” are medically-supervised venues where heroin users can inject heroin in clean, safe, and medically-supervised facilities, and where overdose prevention medication (naloxone) is ready for use if needed.
While not new in international settings (Vancouver utilizes this approach), to date there are no safe consumption sites in the United States. Seattle is currently considering such a program, and it has prompted much discussion and some opposition.
Those opposed to safe consumption sites typically voice concerns about these facilities increasing heroin use, with the assumption that safe places to use heroin will bring more users. Some feel that this approach validates heroin use, sending the message to users that it’s fine to keep using heroin. Other common concerns are that this approach will result in increased drug use in the vicinity of the sites, and that making heroin use easier will decrease the number of heroin users interested in seeking the care of opioid treatment programs.
A review of the literature shows little evidence supporting these concerns, and offers evidence that in Canada and Australia, safe consumption sites have not had the negative impacts cited. There also appears to be no reduction in admission to opioid treatment programs.
While in Seattle there appears to be wide-spread consensus among political and policy leaders about moving forward with these facilities, it remains to be seen whether such a consensus can trump the strongly held beliefs of citizens opposing this harm-reduction-based approach to the opioid use epidemic.
Posted on April 28, 2017 by Pharmaciststeve
Schenectady County Jail medical staff failed to provide proper medication to a man with a variety of ailments, leading to his death last year, a new lawsuit contends.
Jimmy Richardson, 53, of Emmett Street, died at the jail Jan. 17, 2016, of a heart issue. The lawsuit contends he managed his health concerns outside the jail, but that the jail medical staff contributed to his death by withholding some medication and changing pain medication.
“While [Richardson] was obviously not the healthiest person, he had been successfully managing his medical conditions for several years. It was not until the defendants denied him his medication for several weeks … that [Richardson] died,” the suit reads, adding that the defendants’ actions caused his death.
Richardson’s widow, Bernita Richardson, filed the suit last week in federal court in Albany seeking unspecified damages. Attorney E. Robert Keach is representing the estate.
Named as defendants are the jail’s medical provider Correctional Medical Care, Schenectady County and individuals connected to the jail and medical provider.
Schenectady County Attorney Christopher Gardner on Thursday said the county is reviewing the case, but reserved comments on the allegations.
Correctional Medical Care President Emre Umar issued a statement Friday saying that, while the company is “always saddened to learn about any loss of life or negative medical outcome,” it “stands by the quality of services provided.”
Umar noted that jails house “a population with the highest levels of chronic disease, mental health and substance-abuse problems,” and the company employs thousands of qualified and caring professionals.
“It has become a cottage industry for some plaintiffs’ attorneys to abuse public perception and distort and exaggerate facts under the pretense that they care about this patient population, doing so for their own personal financial gain,” Umar’s statement reads. “This complaint, like any other, will go through the litigation process to separate facts from unfounded allegations.”
According to the lawsuit, Richardson “died a preventable death.”
Richardson suffered from a series of ailments, including a cardiac disease called Brugada’s Syndrome that can cause sudden death. He took various medications to address his conditions. He also took strong opiate pain medication that can cause withdrawal symptoms if stopped, the suit reads.
Richardson was jailed twice in the weeks leading up to his death, first for five days in December 2015, then again starting Jan. 4, 2016.
The suit alleges he wasn’t provided with any of his medication in his first stint at the jail and that records showing he received medication from the start of his second stint are fabricated.
The suit notes that attorneys are still waiting for Richardson’s pharmacy records, but based the fabrication allegations on a medical provider’s note in conflict with his jail medical records and numerous handwritten “sick call” slips written by Richardson. He wrote in one dated Jan. 11, 2016, included in the suit “I am Hurting so Bad I need Help!!!”
Medical records did record that Richardson did not receive any pain medication beyond Tylenol until Jan. 13, 2016, the suit reads, due to an apparent problem with a prescription written by a jail doctor.
However, the prescription also changed his pain medication to morphine without consulting his personal doctor. He then received overdoses, the suit alleges.
The night before he died, the suit alleges that Richardson again sought help and was in “obvious need of medical assistance,” but a corrections officer threatened him with disciplinary action and denied him care.
“The case is obviously in the early stages and we need more information,” Keach said Thursday, “but Mr. Richardson’s death is certainly indicative of a disturbing pattern of deaths at correctional facilities where health care is overseen by Correctional Medical Care.”
Keach has brought lawsuits for other deaths at the Schenectady County Jail and elsewhere related to Correctional Medical Care’s work.
He filed a lawsuit in January over the death of 57-year-old Michael Revels, alleging Schenectady County Jail medical officials continually interrupted his medication, leading to his November 2015 death. That case remains pending.
Keach earlier won a $425,000 settlement in a 2013 Schenectady County Jail death and an undisclosed settlement in the 2014 suicide of an inmate at the jail after his suit contended he sought help for depression.
Any settlements involve no county money as part of the county’s agreement with the company, Gardner has said.
Correctional Medical Care’s contract with the county ran out in December and has been extended through June, Gardner said. The county is preparing a request for proposals to determine whether Correctional Medical Care or another company gets the next contract, Gardner said.
Posted on April 28, 2017 by Pharmaciststeve
SALT LAKE CITY – Utah health leaders unveiled a new plan to help fight opioid overdoses.
Drop in at any pharmacy across the state during the month of May, and you’ll notice stickers on the bottle caps of prescription opioids.
“Every time a patient opens that bottle, they’ll see that sticker and be reminded, ‘Hey, this is kind of a dangerous medication,” said Greg Jones, Director of the Pharmacy at Harmons, and the Chair of the Utah Board of Pharmacy.
It’s part of a new campaign called, “Talk to Your Pharmacist Month.” The label serves as a cue to talk to your pharmacist about the dangers of taking opioid prescriptions.
“Our bodies can build tolerance to opioids, meaning we need to take more to get the same effect. This drug tolerance can lead to physical dependence, addiction, abuse, and even overdose,” said Dr. Angela Dunn, Deputy State Epidemiologist for the Utah Department of Health.
Twenty-four Utahns lose their lives every month to prescription opioid overdoses. The Utah Department of Health and Utah Pharmacy Association are working to prevent deaths in our state. Often times, people don’t recognize what they are.
“If you’re not sure, ask your prescriber, ask your pharmacist when you pick the prescription up, and they can help you better understand,” Jones said.
Health leaders point to their data that shows a troubling trend.
In January of 2016, there were more than 21,000 opioid prescriptions written by 9,000 prescribers. That’s a monthly average of 23 opioid prescriptions per prescriber.
“We also know that females receive more opioid prescriptions than males. Males are prescribed more high dosages,” Dunn said.
People underestimate the dangers of opioids.
“They think my doctor gave me this prescription. My pharmacist filled it. I’m gonna be just fine,” Jones said. “And they don’t understand how dangerous the medications can be by themselves, and especially taken with other medications.”
You can also pick up Naloxone over the counter. It’s a life-saving drug that can reverse the effects of an opioid overdose. Here’s information on where and how to get a naloxone kit.
“If you’re prescribed an opioid you can pick that Naloxone kit up for yourself, or if you’re concerned about one of your children or you’re a caregiver for a parent, you can pick up that prescription as well,” Jones said.
Saturday, April 29 from 10 a.m. to 2 p.m. is National Drug Take Back Day. It’s a good opportunity for you to clean out your medicine cabinets and dispose of the old prescription medications you have lying around.
Posted on April 28, 2017 by Pharmaciststeve
Even with red flags. How many Rx’s we fill would be argued as legit if we say no ? The bop visiting if you say no! To their law of corresponding responsibility: This from Tony Park. (See 733 in BOP law book) More good news from professor Park : our white lie? You know : gee sorry we’re out of norco ? The bop is responding to complaint and citing and fining if pharmacies say we’re out n pt complains to bop. Bop visits and does a back count. “
Pharmacists are damned if they do and if they don;t, they have their licenses taken, all because management and corporations will not provide manpower and workplace issues, all due to OBRA 90 laws.
This showed up in my inbox today…it would appear that the California Board of Pharmacy is taking complaints from pts seriously when they are told that the pharmacy “does not have inventory” or lies to pts in some other manner to deny a pt from getting a legit/on time/medically necessary prescription filled.
By Federal law, all pharmacies are required to keep a perpetual physical inventory on all C-II’s. So if a audit is done on a medication to see if a pharmacy did in fact have inventory on hand when the Pharmacist claims that the pharmacy is “out of stock” and declines/refused to fill a valid/on time/medically necessary prescription… it would take only a few minutes to confirm/deny having inventory on hand at the time the pt presented a prescription.
733. Dispensing Prescription Drugs and Devices
(a) A licentiate shall not obstruct a patient in obtaining a prescription drug or
device that has been legally prescribed or ordered for that patient. A violation
of this section constitutes unprofessional conduct by the licentiate and shall subject the licentiate to disciplinary or administrative action by his or her licensing agency.
(b) Notwithstanding any other law, a licentiate shall dispense drugs and
devices, as described in subdivision (a) of Section 4024, pursuant to a lawful order or prescription unless one of the following circumstances exists:
(1) Based solely on the licentiate’s professional training and judgment,
dispensing pursuant to the order or the prescription is contrary to law, or the
licentiate determines that the prescribed drug or device would cause a harmful
drug interaction or would otherwise adversely affect the patient’s medical condition.
(2) The prescription drug or device is not in stock. If an order, other than an
order described in Section 4019, or prescription cannot be dispensed because
the drug or device is not in stock, the licentiate shall take one of the following
(A) Immediately notify the patient and arrange for the drug or device to be
delivered to the site or directly to the patient in a timely manner.
(B) Promptly transfer the prescription to another pharmacy known to stock the
prescription drug or device that is near enough to the site from which the
prescription or order is transferred, to ensure the patient has
timely access to the drug or device.
(C) Return the prescription to the patient and refer the patient. The licentiate
shall make a reasonable effort to refer the patient to a pharmacy that stocks the
prescription drug or device that is near enough to the referring site to ensure
that the patient has timely access to the drug or device.
(3) The licentiate refuses on ethical, moral, or religious grounds to dispense a
drug or device pursuant to an order or prescription. A licentiate may decline to
dispense a prescription drug or device on this basis only if the licentiate has
previously notified his or her employer, in writing, of the drug or class of drugs
to which he or she objects, and the licentiate’s employer can, without creating
undue hardship, provide a reasonable accommodation of the licentiate’s
objection. The licentiate’s employer shall establish protocols that ensure that
the patient has timely access to the prescribed drug or device despite the licentiate’s refusal to dispense the prescription or order. For purposes of this section, “reasonable accommodation” and “undue hardship” shall have the same meaning as applied to those terms pursuant to subdivision (l) of Section 12940 of the Government Code.
(c) For the purposes of this section, “prescription drug or device” has the same meaning as the definition in Section 4022.
(d) This section applies to emergency contraception drug therapy and self- administered hormonal contraceptives described in Section 4052.3.191
(e) This section imposes no duty on a licentiate to dispense a drug or device pursuant to a prescription or order without payment for the drug or device, including payment directly by the patient or through a third-party payer accepted by the licentiate or payment of any required copayment by the patient.
(f) The notice to consumers required by Section 4122 shall include a statement
that describes patients’ rights relative to the requirements of this section.
- 1 DEA BS: Prescription Drug Take Back Helps Curb Opioid Addiction
- 2 National Drug Take Back Day
- 3 Drug Middleman Could Be Charging You More Than Your Medicine Costs
- 4 Yes, people can die from opiate withdrawal
- 5 Bureaucrats: will they listen to common sense ???
- 6 Chronic fatigue syndrome linked with differences in gut bacteria
- 7 Could “safe consumption sites” help the heroin epidemic in the US?
- 8 Going to jail… could be a “DEATH SENTENCE” ?
- 9 UTAH: Bureaucrats concerned about 9000 prescribers writing
- 10 “You can’t just refuse to fill a legitimate prescription issued for a legitimate purpose.”